Ranked by total raised · 25 of 40 on the roster
Biotech using cellular reprogramming to restore cell health and reverse aspects of aging, injury, and disease.
Epigenetic reprogramming biotech using transcription factors to restore youthful gene expression in aging cells, starting with the liver.
Generative-AI drug discovery company developing therapeutics framed around extending human productive longevity.
22 more companies in this ranking, plus every other sort, every roster row, and the full analytical layer behind each profile.
Already subscribed? Sign in →
Membership health platform pairing 100+ biomarker lab tests with whole-body imaging and AI-driven interpretation.
AI-enabled longevity drug company and holding group building a pipeline of medicines to extend healthy human lifespan.
Clinical-stage company developing the first FDA-track drugs to extend healthy lifespan in dogs.
Distributed 'PipeCo' building a portfolio of therapeutics that target the biological drivers of aging to extend healthspan.
Membership network of preventive 'longevity clinics' using whole-body MRI and AI imaging to detect disease before symptoms.
Cryopreservation startup pursuing reversible whole-body cryopreservation, starting with organ preservation for transplant.
Direct-to-consumer longevity supplement brand built around clinically studied NAD+ and cellular-aging products.
Bryan Johnson's 'Don't Die' brand productizing his longevity protocol into supplements, food, and biomarker tracking.
Clinical-stage developer of small-molecule senolytics that selectively clear pathologic senescent cells driving age-related disease.
Clinical-stage Swiss biotech developing small-molecule mitophagy inducers to treat age-related and chronic diseases.
Develops mRNA-based epigenetic reprogramming medicines for age-related conditions via its ERA platform, with an early focus on skin.
Seattle biotech using a non-viral lipid delivery platform to deliver gene-directed payloads that destroy senescent cells.
UK biotech using AI and aging clocks to discover single-gene factors that safely rejuvenate cells, led by its SB000 target.
Longevity-diagnostics company whose SystemAge test scores biological aging across 19 physiological systems from a blood sample.
Combination gene therapies targeting the biology of aging and age-related disease in companion animals and humans.
Membership-based longevity-medicine platform pairing at-home blood panels and clinician access with supplements and hormone therapies.
Consumer longevity brand offering an at-home epigenetic-age test plus a membership of supplements and personalized recommendations.
Direct-to-consumer longevity company pairing science-based supplements with at-home epigenetic and pace-of-aging testing.
Utrecht spinout developing FOXO4-derived senolytic peptides to selectively destroy senescent cells in cancer and chronic disease.
The largest cryonics nonprofit, preserving legally-dead members at cryogenic temperatures in hope of future revival.
NASDAQ-listed clinical-stage biotech mining human aging data to discover metabolic and inflammatory-aging drugs.
Alphabet's aging-research company applying deep biology and drug discovery to age-related disease.